Empirical Finance, LLC
Position in ADAPY — Adaptimmune Therapeutics PLC
CIK 1572838
NEWTOWN SQUARE, PA
Position in ADAPY
as of Dec 31, 2025
· filed Feb 12, 2026
Position Value
$20,800
-$83,200 QoQ
Shares Held
800,000
0.0% QoQ
Ownership
0.050%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ADAPY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Empirical Finance, LLC holds $8,529,315 across 6 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,986 | $4,463,615 | |
| 2 | INCY |
Incyte Corp
|
12,461 | $1,412,578 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,482 | $924,086 | |
| 4 | PTCT |
Ptc Therapeutics, Inc.
|
9,226 | $752,564 | |
| 5 | MRNA |
Moderna, Inc.
|
9,426 | $660,102 | |
| 6 | TECH |
BIO-TECHNE Corp
|
4,478 | $316,370 |
All Filings in ADAPY
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-12-31 | $20,800 | 800,000 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $104,000 | 800,000 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $192,000 | 800,000 | Shares | Sole | 2025-08-11 | |
| No filing history on record for this holder in this stock. | ||||||